# Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis

> **NCT06146972** · PHASE4 · UNKNOWN · sponsor: **Yanfeng Hou** · enrollment: 117 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Therapy

## Interventions

- **DRUG:** Iguratimod

## Key facts

- **NCT ID:** NCT06146972
- **Lead sponsor:** Yanfeng Hou
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2024-03-24
- **Final completion:** 2024-05-31
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2024-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06146972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06146972, "Efficacy Study of Iguratimod Combined With Tofacitab in Patients With RF Positive/Negative Rheumatoid Arthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06146972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*